Most Read Articles
Stephen Padilla, 18 Feb 2020
A wearable, hermetically sealed high-precision vibration sensor enables simultaneous monitoring of multiple health factors associated with the cardiopulmonary system, including heart and respiratory rates, heart sounds, lung sounds, and body motion and position of an individual, a study shows.
Tristan Manalac, 14 Feb 2020
The use of e-cigarettes with flavoured juices for weight-related reasons appears to be common among adolescents, according to a new study.
Pearl Toh, 04 Feb 2020
Four months of daily rifampicin is safer than 9 months of daily isoniazid when it comes to treating latent tuberculosis (TB) infection, according to a post hoc safety analysis on pooled data from two randomized studies* — thus rendering the ambitious goal by the WHO to treat 30 million patients by 2022 possible.
Jairia Dela Cruz, 02 Feb 2018
Children born to mothers who used acid-suppressive drugs, including histamine-2 receptor antagonists and proton pump inhibitors, during pregnancy are at greater risk of developing asthma, according to a systematic review and meta-analysis.

Osteopontin gene expression tied to disease severity in pulmonary arterial hypertension

18 Oct 2019

There appears to be a “highly expressed” osteopontin in the lungs of patients with severe pulmonary arterial hypertension (PAH), and this level of expression is significantly associated with disease severity, according to a study, suggesting a major role for osteopontin in the vascular remodelling process of PAH.

Osteopontin was one of the top five upregulated genes in PAH relative to normal controls. This was confirmed by reverse transcription polymerase chain reaction. Moreover, osteopontin was similar and equally elevated in different PAH subtypes.

Osteopontin gene expression showed a strongly significant association with mean pulmonary arterial pressure (PAP). In ingenuity pathway analysis, osteopontin was found to be involved in functions and networks relevant to angiogenesis, cell death and proliferation of pulmonary artery smooth muscle cells (PA‐SMC). Furthermore, no difference was found in osteopontin serum levels between patients with group I PAH and group II pulmonary hypertension (PH).

In this study, the authors conducted microarray analysis after extracting RNA from explanted lungs in 15 patients with group I PAH who underwent lung transplantation and 11 normal controls. They recorded PAP levels intraoperatively immediately before start of lung transplantion.

Serum osteopontin levels were measured in patients with PAH, group II PH and normal controls on the day of right heart catheterization.

“Osteopontin is a pleiotropic cytokine involved in the proliferation of PA‐SMC,” the authors explained. “Osteopontin is upregulated in the lungs of patients with PH associated with pulmonary fibrosis, suggesting that the lung is a source of osteopontin.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 18 Feb 2020
A wearable, hermetically sealed high-precision vibration sensor enables simultaneous monitoring of multiple health factors associated with the cardiopulmonary system, including heart and respiratory rates, heart sounds, lung sounds, and body motion and position of an individual, a study shows.
Tristan Manalac, 14 Feb 2020
The use of e-cigarettes with flavoured juices for weight-related reasons appears to be common among adolescents, according to a new study.
Pearl Toh, 04 Feb 2020
Four months of daily rifampicin is safer than 9 months of daily isoniazid when it comes to treating latent tuberculosis (TB) infection, according to a post hoc safety analysis on pooled data from two randomized studies* — thus rendering the ambitious goal by the WHO to treat 30 million patients by 2022 possible.
Jairia Dela Cruz, 02 Feb 2018
Children born to mothers who used acid-suppressive drugs, including histamine-2 receptor antagonists and proton pump inhibitors, during pregnancy are at greater risk of developing asthma, according to a systematic review and meta-analysis.